Valo Therapeutics Company

Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Technology: Cell-based gene therapy, Viral Vectors
Industry: Covid-19, Private
Headquarters: Helsinki, Southern Finland, Finland
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 2
Total Funding: 11601987
Estimated Revenue: $10M to $50M
Last Funding Date: 2023-02-14
Last Funding Type: Grant

Visit Website
info@valotx.com
https://twitter.com/ValoTherapeuti1
Register and Claim Ownership